Medtronic Approves Cash Dividend
Medtronic's board of directors has approved a cash dividend of $0.72 per ordinary share for the second quarter of fiscal year 2027. The declaration is consistent with the company's established dividend policy.
Medtronic plc (NYSE:MDT), a global leader in medical technology, announced on Thursday, August 20, 2026, that its board of directors has declared a cash dividend for the second quarter of fiscal year 2027. The dividend is set at $0.72 per ordinary share.
The declaration aligns with the company's consistent dividend policy and is scheduled to be paid on October 10, 2026, to shareholders of record as of September 18, 2026.
Medtronic, headquartered in Ireland, develops and manufactures a wide range of devices and therapies for chronic diseases. This consistent dividend payment signals the company's ongoing financial stability and commitment to returning value to its shareholders.